H1B Salary Data

Home › Employers › Bello Bio LLC

Bello Bio LLC: H-1B salaries and sponsorship

Bello Bio LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 1. Median offered salary: $68,000.

Applications (LCAs)3
Certified1
Employer addressScottsdale, AZ
H-1B dependent employerYes
Median offered salary$68,000
Middle half of salaries$68,000–$68,000
10th–90th percentile$68,000–$68,000

An H-1B dependent employer has a large share of H-1B workers (for example 15% or more of a workforce of 51 or more) and must follow extra rules against displacing U.S. workers.

Does Bello Bio LLC sponsor H-1B visas?

Bello Bio LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 12, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Chief Scientific Officer3$68,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20233$68,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Chief Scientific Officer$68,000–$80,000
Level I
Scottsdale, AZMar 12, 2023Apr 1, 2023Certified
Chief Scientific Officer$68,000–$80,000
Level I
Scottsdale, AZMar 8, 2023Apr 1, 2023Denied
Chief Scientific Officer$68,000–$80,000
Level I
Scottsdale, AZMar 6, 2023Apr 1, 2023Denied

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).